Optimizing PharmacoTherapy In the Multimorbid Elderly in Primary CAre: the OPTICA Trial

NACompletedINTERVENTIONAL
Enrollment

323

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

February 15, 2021

Study Completion Date

February 15, 2021

Conditions
MultimorbidityPolypharmacy
Interventions
DEVICE

STRIPA intervention

"STRIPA is a Dutch software-based tool for the support of the pharmaceutical analysis by 1) taking into account the predictable adverse medication effects, 2) advising safe and appropriate therapy using established STOPP/START criteria, 3) interaction monitoring, and 4) appropriate dosing in accordance with renal function. It represents a highly efficient and user-friendly software engine, which is capable of individually screening the clinical status and pharmacological therapy of older patients with multimorbidity, which can define optimal drug therapy, and which can highlight the adverse drug reaction risk. A summary of these outputs will be used as STRIPA recommendations, which will, if applicable, be implemented by GPs and patients.~Prior to the STRIPA medication review, the necessary patient information will be loaded from the FIRE database that contains data from more than 300 Swiss GP practices."

OTHER

Sham intervention

Patients being assigned to the control arm will be treated in accordance with standard care. They will receive a sham intervention, which consists of a usual medication review by their GP and a shared decision making between patient and GP.

Trial Locations (1)

3012

Berner Institut für Hausarztmedizin, BIHAM, Bern

All Listed Sponsors
collaborator

Utrecht University

OTHER

collaborator

University of Basel

OTHER

collaborator

University of Zurich

OTHER

collaborator

Swiss National Science Foundation

OTHER

lead

University of Bern

OTHER

NCT03724539 - Optimizing PharmacoTherapy In the Multimorbid Elderly in Primary CAre: the OPTICA Trial | Biotech Hunter | Biotech Hunter